Publications by authors named "Julie S Shepard"

Claim this Profile
C
Clesrovimab for Prevention of RSV Disease in Healthy Infants.
Heather J Zar, Eric A F Simões, Shabir A Madhi, Octavio Ramilo, Shelly D Senders, Julie S Shepard

N Engl J Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants.
Shabir A Madhi, Eric A F Simões, Armando Acevedo, Jose M Novoa Pizarro, Julie S Shepard

J Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
Joel Schlessinger, Julie S Shepard, Richard Gower, John C Su, Charles Lynde

Am J Clin Dermatol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant administration of hepatitis A vaccine with measles/mumps/rubella/varicella and pneumococcal vaccines in healthy 12- to 23-month-old children.
Robert J Yetman, Julie S Shepard, Anton Duke, Jon E Stek, Maria Petrecz

Hum Vaccin Immunother· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.
Mark M Blatter, Nicola P Klein, Julie S Shepard, Michael Leonardi, Steven Shapiro

Pediatr Infect Dis J· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis